M. Dulewicz

发表

The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients

B. Mroczko, Monika Zajkowska, L. Kozłowski, 2022, Journal of clinical medicine.

Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis

J. Kochanowicz, B. Mroczko, A. Kułakowska, 2022, Journal of clinical medicine.

Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria

P. Lewczuk, J. Kornhuber, B. Mroczko, 2022, International journal of molecular sciences.

Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis

A. Słowik, B. Mroczko, M. Dulewicz, 2022, International journal of molecular sciences.

Biochemical Markers in Alzheimer’s Disease

B. Mroczko, Alessandro Rabbito, M. Dulewicz, 2020, International journal of molecular sciences.

Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

B. Mroczko, Agnieszka Kulczyńska-Przybik, Maciej Dulewicz, 2020, International journal of molecular sciences.

The Implication of Reticulons (RTNs) in Neurodegenerative Diseases: From Molecular Mechanisms to Potential Diagnostic and Therapeutic Approaches

B. Mroczko, M. Dulewicz, A. Kulczyńska-Przybik, 2021, International journal of molecular sciences.

The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases

A. Słowik, J. Kochanowicz, B. Mroczko, 2021, Journal of Clinical Medicine.

The cerebrospinal fluid interleukin 8 (IL‐8) concentration in Alzheimer’s disease (AD)

A. Słowik, B. Mroczko, M. Dulewicz, 2021, Alzheimer's & Dementia.

Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer’s Disease

A. Słowik, B. Mroczko, M. Dulewicz, 2021, Journal of clinical medicine.

Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease

A. Słowik, B. Mroczko, M. Dulewicz, 2021, Journal of clinical medicine.

Tetramodal Chemical Imaging Delineates the Lipid–Amyloid Peptide Interplay at Single Plaques in Transgenic Alzheimer’s Disease Models

K. Blennow, H. Zetterberg, Jörg Hanrieder, 2023, Analytical chemistry.

A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS)

B. Mroczko, M. Dulewicz, M. Łukaszewicz-Zając, 2021, International journal of molecular sciences.

Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease

A. Słowik, B. Mroczko, Monika Zajkowska, 2023, Journal of clinical medicine.

Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury

K. Blennow, H. Zetterberg, T. Karikari, 2023, JAMA network open.

The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer’s Disease

K. Blennow, H. Zetterberg, A. Słowik, 2023, International journal of molecular sciences.

Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology

K. Blennow, M. Thambisetty, T. Karikari, 2023, medRxiv.

Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology

K. Blennow, M. Thambisetty, S. Čučnik, 2024, Nature communications.

Associations between Microglia and Astrocytic Proteins and Tau Biomarkers across the Continuum of Alzheimer’s Disease

K. Blennow, B. Mroczko, M. Dulewicz, 2024, International journal of molecular sciences.